Lec 3

Molecular Basis of Diseases - CANCER

Introduction to Cancer

  • Cancer is a disease characterized by uncontrolled cell growth that can spread throughout the body.

  • It can originate from almost any cell type in the human body consisting of trillions of cells.

  • Normal cell division involves growth, replacement of old or damaged cells; cancer disrupts this orderly process.

Tumors

  • Tumors can be cancerous (malignant) or non-cancerous (benign).

  • Cancerous tumors invade nearby tissues and can metastasize to distant sites.

  • Many cancers form solid tumors, except for blood cancers (e.g., leukemias).

Differences between Cancer Cells and Normal Cells

  • Cancer cells grow without external signals; normal cells need these signals.

  • Cancer cells ignore stop signals, invade other areas, and hijack the blood supply for nutrients.

  • They can evade the immune system and accumulate genetic changes leading to uncontrolled growth.

How Does Cancer Develop?

  • Cancer is primarily a genetic disease caused by alterations in genes regulating cell function.

  • Genetic changes may arise from:

    • Errors during cell division.

    • Environmental damage (e.g., from tobacco, UV rays).

    • Hereditary factors.

  • Risk of cancer increases with age due to reduced capacity to eliminate damaged cells.

Tumor Microenvironment

  • Involves various immune cells, fibroblasts, and blood vessels that influence tumor growth and spread.

Types of Genes that Cause Cancer

  • Proto-oncogenes: Normal role in cell growth; mutations can lead to cancer-causing oncogenes.

  • Tumor Suppressor Genes: Control cell division; mutations can lead to uncontrolled growth.

  • DNA Repair Genes: Fix DNA errors; mutations result in further genetic instability.

Metastasis

  • Metastatic cancer retains the name of the original cancer (e.g., metastatic breast cancer in lungs).

Non-Cancerous Tissue Changes

  • Hyperplasia: Increased cell number with normal appearance.

  • Dysplasia: Abnormal cell appearance with potential for cancer development.

  • Carcinoma in situ: Abnormal cells that do not invade but may become cancerous.

Types of Cancer

  1. Carcinoma: Common, arising from epithelial cells (e.g., adenocarcinoma).

  2. Sarcoma: Forms in bone and soft tissues (e.g., osteosarcoma).

  3. Leukemia: Bone marrow cancers not forming solid tumors; abnormal white blood cells dominate.

  4. Lymphoma: Begins in lymphocytes; includes Hodgkin and non-Hodgkin lymphoma.

  5. Multiple Myeloma: Arises in plasma cells; leads to bone tumors.

  6. Melanoma: Starts in melanocytes; can occur on skin or in pigmented tissues.

  7. Brain and Spinal Cord Tumors: Named based on the cell type in the CNS.

  8. Germ Cell Tumors: Form from reproductive cells; can be benign or malignant.

  9. Neuroendocrine Tumors: Release hormones and can be benign or malignant.

Hallmarks of Cancer

  • Key characteristics driving tumor growth include:

    • Sustained proliferative signaling

    • Evasion of growth suppressors

    • Resistance to cell death

    • Replicative immortality

    • Angiogenesis and invasion/migration of cancer cells

Oncogenes and Tumor Suppressor Genes

  • Oncogenes promote excessive growth when activated (point mutations, amplifications).

  • Tumor suppressor genes inhibit cell proliferation; inactivation contributes to tumor development.

Genetic and Epigenetic Alterations in Cancer

  • Genetic alterations include point mutations, translocations, and amplifications affecting gene function.

  • Epigenetic changes (DNA methylation, histone modifications) affect gene expression without altering sequence.

  • Non-coding RNAs can also play a role in regulating cancer-related processes.

Targeted Therapies for Cancer

  • Kinase Inhibitors and Monoclonal Antibodies: Target specific proteins or pathways (e.g., trastuzumab for HER2-positive breast cancer).

  • Emerging Therapies: Include PARP inhibitors and immunotherapies utilizing the immune system against cancer.

  • Personalized Medicine: Tailors treatment based on individual genetic profiles.